Story thread · 2 reports / 2 sources
Merck signs up to $2.13B license deal with SciBrunch
seekingalpha.com · 11h · first report
How the coverage leans
Across 2 sources · syndicated copies counted once
The coverage
- Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch
medcitynews.com · 2h
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.